The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tofacitinib
Tofacitinib · TOFACITINIB CITRATE 11 mg/1 · Tablet, Extended Release · Oral · Golden State Medical Supply, Inc.
NDC 84677-0048-30 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for tofacitinib (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA218462
- TE code
- AB
- Approval date
- Jun 3, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Tofacitinib (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Ajanta Pharma USA Inc. | TOFACITINIB CITRATE 11 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | TOFACITINIB CITRATE 11 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | TOFACITINIB CITRATE 11 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| U.S. Pharmaceuticals | TOFACITINIB CITRATE 11 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| U.S. Pharmaceuticals | TOFACITINIB CITRATE 22 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tofacitinib — NDC 84677-0048-30," retrieved September 3, 2026, https://drugdashboards.com/drug/84677004830.
Free to cite with attribution — see how the data is put together.